NCT04957511View on ClinicalTrials.gov

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

RecruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

June 29, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Gynecologic CancerImmunotherapyGut Microbiome

Trial Locations (1)

32804

RECRUITING

AdventHealth Cancer Institute, Orlando

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AdventHealth

OTHER

lead

Viome

INDUSTRY

NCT04957511 - Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy | Biotech Hunter | Biotech Hunter